Business
Press Release Aug 21 2024
Marksans Pharma Limited has informed the Exchange regarding a press release dated August 21, 2024, titled "Marksans Pharma Limited s wholly owned subsidiary Relonchem Limited receives Marketing Authorization for its products".
About this update from Marksans Pharma Limited
[{"type":"text","content":" Marksans Pharma Limited has informed the Exchange regarding a press release dated August 21, 2024, titled \"Marksans Pharma Limited s wholly owned subsidiary Relonchem Limited receives Marketing Authorization for its products\". View Attachment","length":372,"tagName":"div"}]